Search

everythinglearnresearchcommunity

for

Search:↓

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

Dupilumab may help treat hair loss and skin color loss in some patients with atopic dermatitis.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Olumiant should be covered for severe alopecia areata if certain conditions are met.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Ritlecitinib provides new treatment options for diverse alopecia areata patients.

Cepharanthine may help treat lung fibrosis by affecting certain immune cells.

Injectable platelet-rich fibrin can safely and effectively treat melasma.

Cyproterone acetate is effective for acne but less so for hirsutism and alopecia, with some side effects and quick menstrual cycle recovery after treatment.

Apremilast improved symptoms in patients with severe skin conditions.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Upadacitinib effectively treats psoriasis and lichen planus together.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

A woman with a skin disorder was found to have hepatitis C, which may be linked, and was safely treated with methotrexate.

Ciproterone acetate improves hair regrowth and acne in most female patients.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

The FDA approved a new Pfizer drug for hair loss in teens.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

PUVA treatment is effective and safe for alopecia areata.

Bicalutamide can reduce female pattern hair loss, especially in those with certain conditions, but has limited effects on other hair loss types.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.